Medical/Pharmaceuticals

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

SHANGHAI and HONG KONG, Dec. 20, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...

2021-12-20 11:01 4965

Japan's MHLW Approves Booster Shot for SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine

The SPIKEVAX® brand name was developed in partnership with Brand Institute, the global leader in pharmaceutical and healthcare-related name development MIAMI, Dec. 20, 2021 /PRNewswire/ -- Brand Institute is proud to announce its successful partnership with Moderna in naming their mRNA COVID-19 v...

2021-12-20 09:00 4773

Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine

* First EUL granted by WHO for a protein-based COVID-19 vaccine * EUL vaccine manufactured and marketed by SII as COVOVAX™ * WHO EUL for Nuvaxovid™ currently under assessment; will be completed following European Medicines Agency (EMA) review GAITHERSBURG, Md. and PUNE, India, Dec. 20, 2021 ...

2021-12-20 08:24 5502

Novo Nordisk among the top 3 Best Places to Work in Singapore for 2021

Singapore, Dec. 20, 2021 Novo Nordisk Singapore, an affiliate of the global healthcare company with more than 95 years of innovation and leadership in diabetes care, has recently been recognized among the top 3 Best Places to Work for 2021. During the assessment, the company received outsta...

2021-12-20 07:25 2553

Antengene Announces NDA Approval by NMPA for XPOVIO®, China's First XPO1 inhibitor, for the Treatment of Adults with Relapsed or Refractory Multiple Myeloma

SHANGHAI and HONG KONG, Dec. 17, 2021 /PRNewswire/ -- Antengene Corporation Limited (the "Company" or "Antengene") is pleased to announce thatATG-010 (selinexor, brand name:XPOVIO®), a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound has received conditional approval for...

2021-12-17 22:27 6279

Westlake Omics Authorized as the Exclusive Distributor and Service Provider of Pressure BioSciences, Inc. in China

HANGZHOU, China, Dec. 17, 2021 /PRNewswire/ -- The Agreement signed by Westlake Omics (Hangzhou) Biotechnology Co., Ltd (hereinafter referred to as Westlake Omics) and Pressure BioSciences, Inc. (hereinafter referred to as PBI) on December 3, 2021 authorized Westlake Omics as the exclusive distrib...

2021-12-17 19:00 2407

Bioscience Animal Health Public Company Limited Accorded the International Innovation Awards 2021 for Angentex® COVID-19 qPCR Detection Kit

SINGAPORE, Dec. 17, 2021 /PRNewswire/ -- Enterprise Asia is pleased to honor 52 award recipients at the International Innovation Awards 2021. Spearheading the Innovation Revolution, the International Innovation Awards which aims to create an innovation ecosystem for enterprises is held annually t...

2021-12-17 18:24 2511

Study on Anti-aging with TCM Strides Forward

SHIJIAZHUANG, China, Dec. 17, 2021 /PRNewswire/ -- The opinions of experts on "Study on Anti-aging with Bazi Bushen Capsules Guided by Qi Collateral Theory" were released inShijiazhuang, Hebei on December 15. According to the opinions, the preliminary research of the project has created the theo...

2021-12-17 17:06 3611

Lipidor expands clinical program, announces investment in new drug development project against acne vulgaris

STOCKHOLM, Dec. 17, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North: LIPI) today announces that it has initiated a preclinical program for a new drug candidate, AKP-08, focused on acne vulgaris (acne). The market for acne medicines amounts to about35 billion SEK per year, which togethe...

2021-12-17 16:10 2858

"academist" and Sysmex R&D Center Europe to Begin Collaborating in Exploring and Nurturing "Research Seeds" in Europe

TOKYO, Dec. 17, 2021 /PRNewswire/ -- academist, Inc., which operates Japan's first academic crowdfunding platform (https://academist-cf.com/?lang=en ), and Sysmex R&D Center Europe GmbH (hereinafter "Sysmex R&D Center Europe,"https://www.sysmex-rdce.com/

2021-12-17 14:00 2489

Transcenta Announces the Appointment of Daniel Weng as CFO

SUZHOU, China, Dec. 17, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the appointment of Da...

2021-12-17 08:30 4823

Global Cord Blood Corporation Announces Rejection of Alternate Ocean Proposal

HONG KONG, Dec. 17, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its Board of Directors (the "...

2021-12-17 05:16 4422

Huawei supports Thailand launch 5G Smart Hospital

BANGKOK, Dec. 16, 2021 /PRNewswire/ -- Thailand Office of The National Broadcasting and Telecommunications Commission (NBTC), Siriraj Hospital, and Huawei Technologies (Thailand) Co., Ltd. on Thursday jointly launched the "Siriraj World Class 5G Smart Hospital."

2021-12-16 19:03 3309

SenseTime Partners with Macau's Kiang Wu Hospital to Advance Smart Health Application with AI

MACAU, Dec. 16, 2021 /PRNewswire/ -- SenseTime, a leading global artificial intelligence (AI) software company, has formed a strategic partnership with Kiang Wu Hospital, one of the largest and oldest hospitals inMacau to advance smart health application and research with AI.

2021-12-16 18:01 3489

BINUS SCHOOL Simprug Announces Students' Participation in an International Scientific Publication about COVID-19

JAKARTA, Indonesia, Dec. 16, 2021 /PRNewswire/ -- BINUS SCHOOL Simprug, an International Baccalaureate (IB)World School in Indonesia, announces that 15 of their high school students have participated in the creation of a scientific journal titledVoice Processing for COVID-19 Scanning and Progn...

2021-12-16 17:02 3344

SenseTime Partners with Macau's Kiang Wu Hospital to Advance Smart Health Application with AI

MACAU, Dec. 16, 2021 /PRNewswire/ -- SenseTime, a leading global artificial intelligence (AI) software company, has formed a strategic partnership with Kiang Wu Hospital, one of the largest and oldest hospitals inMacau to advance smart health application and research with AI.

2021-12-16 16:58 4678

Antengene and XtalPi Announce AI-Driven R&D Collaboration

SHANGHAI and HONG KONG, Dec. 16, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and other life...

2021-12-16 16:30 4444

BioWorld by Clarivate Identifies the Top Six Global Biopharmaceutical Stories and Trends of 2021

Advances in Alzheimer's, innovation in DNA vaccines, increased regulatory collaboration and the evolving impact of Artificial Intelligence, join Covid-19 as key stories and trends of 2021 LONDON, Dec. 16, 2021 /PRNewswire/ -- BioWorld published by Clarivate Plc  (NYSE:CLVT), a global leader in pr...

2021-12-16 16:14 2918

Debiopharm Further Explores the Potential of its Potent, Highly Selective WEE1 Inhibitor Debio 0123 In Phase 1 Cancer Study

Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumors LAUSANNE, Switzerland, Dec. 16, 2021 /PRNewswire/ -- Debiopharm ( www.debiopharm.com ), a Swiss biopharmaceutica...

2021-12-16 16:00 2644

PHASE 3 TRIAL OF SHR8058 EYE DROPS (PERFLUOROHEXYLOCTANE) CONDUCTED BY JIANGSU HENGRUI PHARMACEUTICALS IN THE PEOPLE'S REPUBLIC OF CHINA SHOWS STATISTICALLY SIGNIFICANT TOPLINE RESULTS

HEIDELBERG, Germany, and CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today provided a development update on the phase 3 trial of SHR8058 eye drops ...

2021-12-16 15:00 2789
1 ... 354355356357358359360 ... 382